Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.

Early erythroblasts from patients with refractory anemia (RA) and RA with ringed sideroblasts (RARS) show constitutive mitochondrial release of cytochrome c. Moreover, mature erythroblasts in RARS, but not in RA, display aberrant accumulation of mitochondrial ferritin (MtF). We analyzed cytochrome c release, MtF expression, and gene expression during erythroid differentiation in bone marrow cells from myelodysplastic syndrome (MDS) patients and healthy controls. Whereas none or few cultured erythroid cells from healthy individuals and RA patients expressed MtF, those from RARS patients showed MtF expression at an early stage, when cells were CD34+ and without morphologic signs of erythroid differentiation. The proportion of RARS erythroblasts that were MtF+ increased further upon in vitro maturation. Moreover, a significant overexpression of mRNA encoding cytochrome c, and proapoptotic Bid and Bax, was seen in freshly isolated cells from MDS patients. Genes involved in erythroid differentiation were also dysregulated in MDS cells. Importantly, GATA-1 expression increased during normal erythroid maturation, but remained low in MDS cultures, indicating a block of erythroid maturation at the transcriptional level. In conclusion, aberrant MtF expression in RARS erythroblasts occurs at a very early stage of erythroid differentiation and is paralleled by an up-regulation of genes involved in this process.

[1]  Guangjun Nie,et al.  Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. , 2004, Blood.

[2]  Hao Wang,et al.  Global regulation of erythroid gene expression by transcription factor GATA-1. , 2004, Blood.

[3]  U. Testa,et al.  Apoptotic mechanisms in the control of erythropoiesis , 2004, Leukemia.

[4]  T. Kuijpers,et al.  Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor , 2004, The Journal of Immunology.

[5]  E. Hellström-Lindberg,et al.  Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. , 2004, Haematologica.

[6]  L. Schwartz,et al.  In vitro expansion of human cord blood CD36+ erythroid progenitors: temporal changes in gene and protein expression. , 2003, Experimental hematology.

[7]  K. Akashi,et al.  GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. , 2003, Immunity.

[8]  M. Cazzola,et al.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.

[9]  P. Arosio,et al.  Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells , 2003 .

[10]  B. Zhivotovsky,et al.  Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. , 2003, Blood.

[11]  P. Arosio,et al.  Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. , 2003, FEBS letters.

[12]  D. Tang,et al.  Early Mitochondrial Activation and Cytochrome c Up-regulation during Apoptosis* 210 , 2002, The Journal of Biological Chemistry.

[13]  L. Hagenfeldt,et al.  Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples. , 2002, Analytical biochemistry.

[14]  M. Cazzola,et al.  Mitochondrial ferritin: a new player in iron metabolism. , 2002, Blood cells, molecules & diseases.

[15]  P. Arosio,et al.  Ferritin, iron homeostasis, and oxidative damage. , 2002, Free radical biology & medicine.

[16]  F. Torti,et al.  Regulation of ferritin genes and protein. , 2002, Blood.

[17]  S. Orkin,et al.  Transcriptional regulation of erythropoiesis: an affair involving multiple partners , 2002, Oncogene.

[18]  Sten Orrenius,et al.  Cytochrome c release from mitochondria proceeds by a two-step process , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Kuijpers,et al.  Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. , 2002, Blood.

[20]  A B Cantor,et al.  Hematopoietic development: a balancing act. , 2001, Current opinion in genetics & development.

[21]  Y. Yamashita,et al.  Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. , 2001, Blood.

[22]  B. Joseph,et al.  Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts , 2001, Leukemia.

[23]  S. Dimauro,et al.  The genetics and pathology of oxidative phosphorylation , 2001, Nature Reviews Genetics.

[24]  Bengt Fadeel,et al.  Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases , 2001, British journal of haematology.

[25]  T. Matthes,et al.  Increased apoptosis in acquired sideroblastic anaemia , 2000, British journal of haematology.

[26]  G. Kroemer,et al.  The mitochondrion in cell death control: certainties and incognita. , 2000, Experimental cell research.

[27]  Y. Saunthararajah,et al.  Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? , 2000, Seminars in hematology.

[28]  P. Vogt,et al.  Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Srinivasula,et al.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.

[30]  C. Lacombe,et al.  Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction , 1999, British journal of haematology.

[31]  Parker,et al.  ‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins , 1998, British journal of haematology.

[32]  A. Barrett,et al.  Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte‐mediated inhibition of CFU‐GM and alterations in T‐cell receptor Vβ profiles , 1998, British journal of haematology.

[33]  I. Dybedal,et al.  Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. , 1998, Blood.

[34]  Sten Orrenius,et al.  Injected cytochrome c induces apoptosis , 1998, Nature.

[35]  Y Yoshida,et al.  Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. , 1998, Haematologica.

[36]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[37]  L. Hoefsloot,et al.  Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand. , 1996, Leukemia.

[38]  J. Bennett,et al.  Hypocellular myelodysplastic syndromes (MDS): new proposals , 1995, British journal of haematology.

[39]  M. Carroll,et al.  Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Asano,et al.  Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes. , 1993, International journal of hematology.

[41]  Y. Ikawa,et al.  GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. , 1991, Nucleic acids research.

[42]  G. Stamatoyannopoulos,et al.  Differentiation kinetics and globin gene expression by circulating human BFUe in suspension cultures. , 1990, Experimental hematology.

[43]  H. Uchino,et al.  Refractory myelodysplastic anaemias with hypocellular bone marrow. , 1988, Journal of clinical pathology.